摘要
目的探讨980 nm红激光治疗高龄高危浸润性膀胱癌患者的临床疗效。方法对2011年10月~2014年6月期间6例高龄高危不能耐受根治性全膀胱切除手术的浸润性膀胱癌患者,施行经尿道红激光膀胱肿瘤切除手术,现回顾性分析其临床资料。结果 6例患者术中生命体征均平稳,无闭孔神经反射及膀胱穿孔、尿外渗,手术顺利完成。术后留置尿管3~7 d,平均（3.0±0.6）d;术后住院5~8 d,平均（4.0±0.6）d。术后随访5~36个月,平均（16.0±0.8）月;其中2例复发者再次行红激光膀胱肿瘤切除手术。结论 980 nm红激光治疗高龄高危不能耐受根治性手术的浸润性膀胱癌患者是有效和安全的,具有手术时间短、术中出血少等优点,可以使患者生活质量获得最大限度的提高。
Objective To evaluate clinical efficacy of 980 nm laser for treatment of senior and high risk patients with invasive bladder cancer. Methods Six senior and high risk patients with invasive bladder cancer were treated with 980 nm laser system. These patients could not tolerate radical bladder surgery. The clinical data were retrospectively analyzed.Results The surgical procedure was smooth and safe in 6 patients. There was no case of vesical perforation, reflex of obturator nerve and urinary extravasation. The mean indwelling urethral catheter time was（3.0±0.6）days（ranged from 3 to 7 days）. The average hospitalization time was（4.0±0.6） days（ranged from 5 to 8 days）. The recurrence occurred in 2cases after follow up for average（16.0±0.8） months（ranged from 5 to 36 months）. The relapse cases received operation with 980 nm laser system again. Conclusion 980 nm laser is safe and effective in treatment of senior and high risk patients with invasive bladder cancer, with shorter time and less blood loss. It can improve the maximum level of the quality of life.
出处
《中国现代医生》
2015年第7期25-28,共4页
China Modern Doctor
基金
国家国际合作专项项目(2014DFE30010)
国家自然科学基金(81373637)
